J Physiol Society Membership
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Physiol Volume 511, Number 1, 3-14, August 15, 1998
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Herzberg, I. M.
Right arrow Articles by Robertson, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Herzberg, I. M.
Right arrow Articles by Robertson, G. A.
The Journal of Physiology (1998), 511.1, pp. 3-14
© Copyright 1998 The Physiological Society

Transfer of rapid inactivation and sensitivity to the class III antiarrhythmic drug E-4031 from HERG to M-eag channels

Ian M. Herzberg *, Matthew C. Trudeau * and Gail A. Robertson

Department of Physiology, University of Wisconsin-Madison Medical School, Madison, WI 53706, USA

  1. The gating behaviour and pharmacological sensitivity of HERG are remarkably different from the corresponding properties of M-eag, a structurally similar member of the Eag family of potassium channels. In contrast to HERG, M-eag exhibits no apparent inactivation and little rectification, and is insensitive to the class III antiarrhythmic drug E-4031.

  2. We generated chimeric channels of HERG and M-eag sequences and made point mutations to identify the region necessary for rapid inactivation in HERG. This region includes the P region and half of the S6 putative transmembrane domain, including sites not previously associated with inactivation and rectification in HERG.

  3. Transfer of a small segment of the HERG polypeptide to M-eag, consisting largely of the P region and part of the S6 transmembrane domain, is sufficient to confer rapid inactivation and E-4031 sensitivity to M-eag. This region differs from the corresponding region in M-eag by only fifteen residues.

  4. Previous hypotheses that rapid inactivation of HERG channels occurs by a C-type inactivation mechanism are supported by the parallel effects on rates of HERG inactivation and Shaker C-type inactivation by a series of mutations at two equivalent sites in the polypeptide sequences.

  5. In addition to sites homologous to those previously described for C-type inactivation in Shaker, inactivation in HERG involves a residue in the upstream P region not previously associated with C-type inactivation. Although this site is equivalent to one implicated in P-type inactivation in Kv2.1 channels, our data are most consistent with a single, C-type inactivation mechanism.



This article has been cited by other articles:


Home page
J. Gen. Physiol.Home page
H. Gang and S. Zhang
Na+ Permeation and Block of hERG Potassium Channels
J. Gen. Physiol., June 26, 2006; 128(1): 55 - 71.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
C. E. Clarke, A. P. Hill, J. Zhao, M. Kondo, R. N. Subbiah, T. J. Campbell, and J. I. Vandenberg
Effect of S5P {alpha}-helix charge mutants on inactivation of hERG K+ channels
J. Physiol., June 1, 2006; 573(2): 291 - 304.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Gentile, T. Darden, C. Erxleben, C. Romeo, A. Russo, N. Martin, S. Rossie, and D. L. Armstrong
Rac GTPase signaling through the PP5 protein phosphatase
PNAS, March 28, 2006; 103(13): 5202 - 5206.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. M. Storey, S. Gentile, H. Ullah, A. Russo, M. Muessel, C. Erxleben, and D. L. Armstrong
Rapid signaling at the plasma membrane by a nuclear receptor for thyroid hormone
PNAS, March 28, 2006; 103(13): 5197 - 5201.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Rajamani, C. L. Anderson, C. R. Valdivia, L. L. Eckhardt, J. D. Foell, G. A. Robertson, T. J. Kamp, J. C. Makielski, B. D. Anson, and C. T. January
Specific serine proteases selectively damage KCNH2 (hERG1) potassium channels and IKr
Am J Physiol Heart Circ Physiol, March 1, 2006; 290(3): H1278 - H1288.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Perry, P. J. Stansfeld, J. Leaney, C. Wood, M. J. de Groot, D. Leishman, M. J. Sutcliffe, and J. S. Mitcheson
Drug Binding Interactions in the Inner Cavity of hERG Channels: Molecular Insights from Structure-Activity Relationships of Clofilium and Ibutilide Analogs
Mol. Pharmacol., February 1, 2006; 69(2): 509 - 519.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
M. Jiang, M. Zhang, I. V. Maslennikov, J. Liu, D.-M. Wu, Y. V. Korolkova, A. S. Arseniev, E. V. Grishin, and G.-N. Tseng
Dynamic conformational changes of extracellular S5-P linkers in the hERG channel
J. Physiol., November 15, 2005; 569(1): 75 - 89.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
D. Fernandez, A. Ghanta, K. I Kinard, and M. C Sanguinetti
Molecular mapping of a site for Cd2+-induced modification of human ether-a-go-go-related gene (hERG) channel activation
J. Physiol., September 15, 2005; 567(3): 737 - 755.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Physiol.Home page
M. Zhang, J. Liu, and G.-N. Tseng
Gating Charges in the Activation and Inactivation Processes of the hERG Channel
J. Gen. Physiol., November 29, 2004; 124(6): 703 - 718.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. M. Torres, P. S. Bansal, M. Sunde, C. E. Clarke, J. A. Bursill, D. J. Smith, A. Bauskin, S. N. Breit, T. J. Campbell, P. F. Alewood, et al.
Structure of the HERG K+ Channel S5P Extracellular Linker: ROLE OF AN AMPHIPATHIC {alpha}-HELIX IN C-TYPE INACTIVATION
J. Biol. Chem., October 24, 2003; 278(43): 42136 - 42148.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
G. Seebohm, J. Chen, N. Strutz, C. Culberson, C. Lerche, and M. C. Sanguinetti
Molecular Determinants of KCNQ1 Channel Block by a Benzodiazepine
Mol. Pharmacol., July 1, 2003; 64(1): 70 - 77.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Physiol.Home page
J. Liu, M. Zhang, M. Jiang, and G.-N. Tseng
Negative Charges in the Transmembrane Domains of the HERG K Channel Are Involved in the Activation- and Deactivation-gating Processes
J. Gen. Physiol., May 27, 2003; 121(6): 599 - 614.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
K. Ishii, M. Nagai, M. Takahashi, and M. Endoh
Dissociation of E-4031 from the HERG channel caused by mutations of an amino acid results in greater block at high stimulation frequency
Cardiovasc Res, March 1, 2003; 57(3): 651 - 659.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Physiol.Home page
F. M. Mullins, S. Z. Stepanovic, R. R. Desai, A. L. George Jr., and J. R. Balser
Extracellular Sodium Interacts with the HERG Channel at an Outer Pore Site
J. Gen. Physiol., September 30, 2002; 120(4): 517 - 537.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Chen, G. Seebohm, and M. C. Sanguinetti
Position of aromatic residues in the S6 domain, not inactivation, dictates cisapride sensitivity of HERG and eag potassium channels
PNAS, September 17, 2002; 99(19): 12461 - 12466.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Q. Gong, C. L. Anderson, C. T. January, and Z. Zhou
Role of glycosylation in cell surface expression and stability of HERG potassium channels
Am J Physiol Heart Circ Physiol, July 1, 2002; 283(1): H77 - H84.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
E. Ficker, W. Jarolimek, and A. M. Brown
Molecular Determinants of Inactivation and Dofetilide Block in ether a-go-go (EAG) Channels and EAG-Related K+ Channels
Mol. Pharmacol., December 1, 2001; 60(6): 1343 - 1348.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. L. Greenstein, R. Wu, S. Po, G. F. Tomaselli, and R. L. Winslow
Role of the Calcium-Independent Transient Outward Current Ito1 in Shaping Action Potential Morphology and Duration
Circ. Res., November 24, 2000; 87(11): 1026 - 1033.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
G. A. Robertson
LQT2 : Amplitude Reduction and Loss of Selectivity in the Tail That Wags the HERG Channel
Circ. Res., March 17, 2000; 86(5): 492 - 493.
[Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. P. Lees-Miller, Y. Duan, G. Q. Teng, and H. J. Duff
Molecular Determinant of High-Affinity Dofetilide Binding to HERG1 Expressed in Xenopus Oocytes: Involvement of S6 Sites
Mol. Pharmacol., February 1, 2000; 57(2): 367 - 374.
[Abstract] [Full Text]


Home page
Physiol. Rev.Home page
F. Lehmann-Horn and K. Jurkat-Rott
Voltage-Gated Ion Channels and Hereditary Disease
Physiol Rev, October 1, 1999; 79(4): 1317 - 1372.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H.-Z. Wang, H. Shi, S.-J. Liao, and Z. Wang
Inactivation gating determines nicotine blockade of human HERG channels
Am J Physiol Heart Circ Physiol, September 1, 1999; 277(3): H1081 - H1088.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. Zhang, Z. Zhou, Q. Gong, J. C. Makielski, and C. T. January
Mechanism of Block and Identification of the Verapamil Binding Domain to HERG Potassium Channels
Circ. Res., May 14, 1999; 84(9): 989 - 998.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. C. Trudeau, S. A. Titus, J. L. Branchaw, B. Ganetzky, and G. A. Robertson
Functional Analysis of a Mouse Brain Elk-Type K+ Channel
J. Neurosci., April 15, 1999; 19(8): 2906 - 2918.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 The Physiological Society.